OTCMKTS:AMBBY Ambu A/S Q1 2026 Earnings Report $10.25 0.00 (0.00%) As of 09/18/2026 ProfileEarnings HistoryForecast Ambu A/S EPS ResultsActual EPS$0.07Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AAmbu A/S Revenue ResultsActual Revenue$242.85 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AAmbu A/S Announcement DetailsQuarterQ1 2026Date2/4/2026TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Ambu A/S Earnings HeadlinesAmbu A/S Unsponsored ADR (OTCMKTS:AMBBY) Sees Large Increase in Short InterestSeptember 11, 2026 | americanbankingnews.comAmbu AS ADR AMBBYAugust 28, 2026 | morningstar.comMDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December.September 20 at 1:00 AM | Porter & Company (Ad)3 European Stocks Estimated To Be Undervalued By Up To 47.6%November 18, 2025 | finance.yahoo.comEuropean Growth Companies With Up To 34% Insider OwnershipNovember 14, 2025 | finance.yahoo.comAmbu (CPSE:AMBU B) Valuation: How Improved Results and Guidance Shape Investor SentimentNovember 13, 2025 | finance.yahoo.comSee More Ambu A/S Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Ambu A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ambu A/S and other key companies, straight to your email. Email Address About Ambu A/SAmbu A/S (OTCMKTS:AMBBY) is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. The company focuses on reducing the need to reprocess reusable equipment while supporting clinical procedures in areas such as endoscopy, anesthesia and patient monitoring. Ambu’s product portfolio includes disposable endoscopes and related visualization systems, airway management products, anesthesia equipment and devices used for patient monitoring and diagnostics. Its endoscopy offerings are used in pulmonary, gastrointestinal and other clinical applications, while its anesthesia and airway products support the care of patients before, during and after medical procedures. Founded in 1937 by Holger Hesse, Ambu is headquartered in Ballerup, Denmark, and serves healthcare markets internationally, including Europe, North America and the Asia-Pacific region. The company is led by Chief Executive Officer Britt Meelby Jensen, who has served in that role since 2023.View Ambu A/S ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles J.B. Hunt's Stock Plunges After Market Misprices Profit WarningLennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. HousingThese 3 Stocks Sit at the Center of NVIDIA’s Cybersecurity PushGold Has Gone Sideways, But These 3 Stocks Haven’tLennar's Q3 Miss Hides a Stronger Operating Story Beneath the Housing SlumpAeluma’s Selloff Could Be Setting Up Its Next Big MoveBraze Beat Expectations—Now 2 SaaS Peers Are in Focus Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
